Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra L Turner

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 3, 2006
Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology GroupNirdosh Kumar Gogna, John H L Matthews, Sandra L Turner, et al.
Cancer Epidemiology|May 29, 2016
Patterns and trends in the incidence of paediatric and adult germ cell tumours in Australia, 1982-2011Marina T van Leeuwen, Howard Gurney, Jennifer J Turner, et al.
Journal of Medical Imaging and Radiation Oncology|February 21, 2012
Australian & New Zealand Faculty of Radiation Oncology Genito-Urinary Group: 2011 consensus guidelines for curative radiotherapy for urothelial carcinoma of the bladderBenjamin R Hindson, Sandra L Turner, Jeremy L Millar, et al.
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapyRichard A Cowan, Catherine A McBain, W David J Ryder, et al.
JAMA Network Open|November 1, 2021
Evaluation of Hypofractionated Radiation Therapy Use and Patient-Reported Outcomes in Men With Nonmetastatic Prostate Cancer in Australia and New ZealandDavid I Pryor, Jarad M Martin, Jeremy L Millar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 24, 2020
Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trialEmily A Hewson, Doan T Nguyen, Ricky O'Brien, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 3, 2006
Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology GroupNirdosh Kumar Gogna, John H L Matthews, Sandra L Turner, et al.
Cancer Epidemiology|May 29, 2016
Patterns and trends in the incidence of paediatric and adult germ cell tumours in Australia, 1982-2011Marina T van Leeuwen, Howard Gurney, Jennifer J Turner, et al.
Journal of Medical Imaging and Radiation Oncology|February 21, 2012
Australian & New Zealand Faculty of Radiation Oncology Genito-Urinary Group: 2011 consensus guidelines for curative radiotherapy for urothelial carcinoma of the bladderBenjamin R Hindson, Sandra L Turner, Jeremy L Millar, et al.
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapyRichard A Cowan, Catherine A McBain, W David J Ryder, et al.
JAMA Network Open|November 1, 2021
Evaluation of Hypofractionated Radiation Therapy Use and Patient-Reported Outcomes in Men With Nonmetastatic Prostate Cancer in Australia and New ZealandDavid I Pryor, Jarad M Martin, Jeremy L Millar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 24, 2020
Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trialEmily A Hewson, Doan T Nguyen, Ricky O'Brien, et al.
Pageof 2